Press Releases Year 2003

Wockhardt becomes 1st Indian pharmaceutical company to get EMR December 24, 2003 Credit Policy - Views of Habil Khorakiwala, Wockhardt Chairman November 3, 2003 Wockhardt Third Quarter Unaudited Financial Results, 2003. Net Profit up 45% at Rs. 49 crores, Sales up 34% at Rs. 293 crores October 31, 2003 Wockhardt gets US FDA Approval for Bethanechol. To launch only Generic Alternative in $46m market September 30, 2003 University of Pune recognises Wockhardt Research Centre for PhD programmes September 12, 2003 Wockhardt launches Asia's first human recombinant insulin. Becomes world's fourth producer and first outside US and Europe August 4, 2003 Wockhardt Limited Second Quarter Net up at Rs. 35 crore, Exports up 36% at Rs. 68 crore, Domestic Power Brands grow 16% July 29, 2003 Wockhardt acquires CP Pharmaceuticals of UK. Becomes one amongst Top 10 Generic Pharma Companies in UK July 8, 2003 Merind Business now worth Rs. 349 Crores July 7, 2003 Wockhardt denies plans to sell Vitamin B12 Business June 19, 2003 Wockhardt announces First Quarter Results of 2003. Sales down 9%, Exports up 14% April 30, 2003 Wockhardt announces Financial Results for 2002. Sales up 14% at Rs. 742 crores, International Business jumps 41% to Rs. 242 crores. 29 new patents filed March 27, 2003 Union Budget reaction from Habil Khorakiwala, Chairman, Wockhardt February 28, 2003 Historic Awards to Reward Medical Excellence. Five Doctors Honoured by Harvard Medical International and Wockhardt February 15, 2003

Press Releases 2005   Press Releases Archives Year 2004

Would like to know more about Wockhardt ? Annual Report 2005 Corporate Presentation Chairman’s Letter to Shareowners Investor Update Q2, 2005 Results

Disclaimer:
The company would like to caution that any forward-looking statements or projections made by the company, including those made in the press release announcements, are subject to risks and uncertainties that may cause actual results to differ materially from those projected.